Diabetes drug lowers risk of cardiovascular complications, kidney disease
Tuesday, June 14, 2016 - 10:01
in Health & Medicine
The glucose-lowering drug liraglutide safely and effectively decreases the overall risk of heart attack, stroke, or cardiovascular death, kidney disease, and death from all causes for people with type 2 diabetes, according to data from the large, multinational LEADER clinical trial.